| Flavones: An important scaffold for medicinal chemistry M Singh, M Kaur, O Silakari European journal of medicinal chemistry 84, 206-239, 2014 | 624 | 2014 |
| Acetylcholinesterase inhibitors as Alzheimer therapy: from nerve toxins to neuroprotection M Singh, M Kaur, H Kukreja, R Chugh, O Silakari, D Singh European journal of medicinal chemistry 70, 165-188, 2013 | 421 | 2013 |
| Oxindole: A chemical prism carrying plethora of therapeutic benefits M Kaur, M Singh, N Chadha, O Silakari European Journal of Medicinal Chemistry 123, 858-894, 2016 | 295 | 2016 |
| Thiazolidine-2, 4-dione derivatives: programmed chemical weapons for key protein targets of various pathological conditions N Chadha, MS Bahia, M Kaur, O Silakari Bioorganic & Medicinal Chemistry 23 (13), 2953-2974, 2015 | 127 | 2015 |
| Purinergic receptor P2X7: a novel target for anti-inflammatory therapy N Mehta, M Kaur, M Singh, S Chand, B Vyas, P Silakari, MS Bahia, ... Bioorganic & medicinal chemistry 22 (1), 54-88, 2014 | 117 | 2014 |
| Hybrids: a new paradigm to treat Alzheimer’s disease M Singh, M Kaur, N Chadha, O Silakari Molecular diversity 20, 271-297, 2016 | 97 | 2016 |
| Inhibitors of switch kinase ‘spleen tyrosine kinase’in inflammation and immune-mediated disorders: a review M Kaur, M Singh, O Silakari European journal of medicinal chemistry 67, 434-446, 2013 | 65 | 2013 |
| Interleukin-1 receptor associated kinase inhibitors: potential therapeutic agents for inflammatory-and immune-related disorders MS Bahia, M Kaur, P Silakari, O Silakari Cellular signalling 27 (6), 1039-1055, 2015 | 54 | 2015 |
| Synthesis, cytotoxic study and docking based multidrug resistance modulator potential analysis of 2-(9-oxoacridin-10 (9H)-yl)-N-phenyl acetamides R Kumar, M Kaur, MS Bahia, O Silakari European Journal of Medicinal Chemistry 80, 83-91, 2014 | 49 | 2014 |
| Benzimidazoles: an ideal privileged drug scaffold for the design of multitargeted anti-inflammatory ligands G Kaur, M Kaur, O Silakari Mini reviews in medicinal chemistry 14 (9), 747-767, 2014 | 48 | 2014 |
| Designing of new multi-targeted inhibitors of spleen tyrosine kinase (Syk) and zeta-associated protein of 70 kDa (ZAP-70) using hierarchical virtual screening protocol M Kaur, A Kumari, MS Bahia, O Silakari Journal of Molecular Graphics and Modelling 39, 165-175, 2013 | 38 | 2013 |
| Dual inhibitors of Janus kinase 2 and 3 (JAK2/3): designing by pharmacophore-and docking-based virtual screening approach H Jasuja, N Chadha, M Kaur, O Silakari Molecular diversity 18, 253-267, 2014 | 37 | 2014 |
| Benzimidazole–ibuprofen/mesalamine conjugates: Potential candidates for multifactorial diseases Y Bansal, M Kaur, O Silakari European Journal of Medicinal Chemistry 89, 671-682, 2015 | 36 | 2015 |
| Enhanced methane yield by photoreduction of CO2 at moderate temperature and pressure using Pt coated, graphene oxide wrapped TiO2 nanotubes AD Devi, S Pushpavanam, N Singh, J Verma, MP Kaur, SC Roy Results in Engineering 14, 100441, 2022 | 32 | 2022 |
| Diabetes and antidiabetic herbal formulations: an alternative to Allopathy M Kaur, V Valecha Eur. J. Med 6 (4), 226-240, 2014 | 32 | 2014 |
| Exploration of multi-target potential of chromen-4-one based compounds in Alzheimer’s disease: Design, synthesis and biological evaluations M Singh, M Kaur, N Singh, O Silakari Bioorganic & Medicinal Chemistry 25 (24), 6273-6285, 2017 | 30 | 2017 |
| Design, synthesis and biological evaluation of 2-Phenyl-4H-chromen-4-one derivatives as polyfunctional compounds against Alzheimer’s disease M Singh, M Kaur, B Vyas, O Silakari Medicinal Chemistry Research 27, 520-530, 2018 | 27 | 2018 |
| Inhibitors of interleukin-2 inducible T-cell kinase as potential therapeutic candidates for the treatment of various inflammatory disease conditions M Kaur, MS Bahia, O Silakari European journal of pharmaceutical sciences 47 (3), 574-588, 2012 | 27 | 2012 |
| Oxindole-based SYK and JAK3 dual inhibitors for rheumatoid arthritis: designing, synthesis and biological evaluation M Kaur, M Singh, O Silakari Future medicinal chemistry 9 (11), 1193-1211, 2017 | 23 | 2017 |
| Insight into the therapeutic aspects of ‘Zeta-Chain Associated Protein Kinase 70 kDa’inhibitors: A review M Kaur, M Singh, O Silakari Cellular signalling 26 (11), 2481-2492, 2014 | 21 | 2014 |
